Impact of definitive radiotherapy on metabolic response measured with 68 Ga-PSMA-PET/CT in patients with intermediate-risk prostate cancer.
Cem OnalOzan C GulerNese TorunAysenur ElmaliPhilip SuteraMatthew P DeekMehmet ReyhanMelek YavuzPhuoc T TranPublished in: The Prostate (2024)
Ga-PSMA-PET/CT is not feasible for those treated with RT alone, and it may only be useful in better distinguishing patients with and without PSA nadir for those who received both RT and ADT.